Prometic

Prometic is a biopharmaceutical corporation with two drug discovery platforms focusing on unmet medical needs in the field of fibrosis and orphan diseases. We are committed to providing patients throughout the world with hope of a healthier future and are doing this by:

  • advancing our new discoveries within the lifecycle of healing through the clinical trial stages and regulatory approval process
  • targeting specific unmet medical needs using our proprietary small molecule and plasma-derived drug candidates
  • building a deep and rich R&D pipeline, enabled through world-class science

We are headquartered in Laval, Quebec (Canada), and have R&D facilities in Canada, the United States (“USA”) and United Kingdom (“UK”), manufacturing facilities in Canada and the Isle of Man and corporate and business development activities in Canada, the USA, Europe and Asia. These are strategic locations established to support and facilitate our growth and business activities globally.

Prometic is now focused on completing its transition from a pure R&D company into a commercially successful pharmaceutical company specialized in rare and orphan diseases with the foundations to enable significant growth over the coming years. Prometic is publicly traded on TSX (Symbol: PLI) and OTCQX (Symbol: PFSCF).

Prometic Job Offers